Annual report
5199.TEDINET S100W2HG
Period2024-04-01 → 2025-03-31
Filed2025-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 146
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥7.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥8.1bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥209m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥440m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥171m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥382m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥730m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥486m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥227m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥383m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥376m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥298m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥290m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥517m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥143m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥170m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥298m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥290m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥11.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥11.3bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥11.5bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥11.8bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥12.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.0bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.6bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.3bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥634m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥211m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥772m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥706m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥278m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥123m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥76m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥152m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥111m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥282m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥347m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥676m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥803m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥450m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥235.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥228.42 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥407.89 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-112.56 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.03 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,209.1 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,042.65 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,820.6 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,442.65 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,604.82 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 36.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.2% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.6% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.5% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 250 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 278 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 276 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 287 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 285 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥7.1bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥7.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥8.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥204m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥426m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥167m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥370m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥714m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥496m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥213m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥379m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥363m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥297m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥283m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥504m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥167m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥160m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥10.9bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥11.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥11.4bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.7bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.4bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥7.5bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.8bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.5bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.0bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥234.59 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥223.35 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥397.23 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-131.92 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥125.82 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥78 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,091.45 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,964.09 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,760.74 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,388.09 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,575.31 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.8% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.7% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.4% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,286,199 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 245 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 272 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 272 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 281 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 279 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥6m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥16m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥3.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥455m |
| Medical Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥43m |
| Medical Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥104m |
| Medical Equipmentreportable segment | employees | at 2025-03-31 | 87 pure |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Medical Equipmentreportable segment | segment assets | at 2025-03-31 | ¥3.5bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥8m |
| Precision Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥77m |
| Precision Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥141m |
| Precision Equipmentreportable segment | employees | at 2025-03-31 | 121 pure |
| Precision Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.1bn |
| Precision Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.1bn |
| Precision Equipmentreportable segment | segment assets | at 2025-03-31 | ¥3.6bn |
| Precision Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥710m |
| SP Divisionreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥24,000 |
| SP Divisionreportable segment | employees | at 2025-03-31 | 1 pure |
| SP Divisionreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥390m |
| SP Divisionreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥390m |
| SP Divisionreportable segment | segment assets | at 2025-03-31 | ¥84m |
| SP Divisionreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥23m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥217m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥271m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥664m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥21m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥23m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥467m |
| Medical Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥24m |
| Medical Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥111m |
| Medical Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.4bn |
| Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.4bn |
| Medical Equipmentreportable segment | segment assets | at 2024-03-31 | ¥3.8bn |
| Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥9m |
| Precision Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥65m |
| Precision Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥159m |
| Precision Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥4.2bn |
| Precision Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥4.2bn |
| Precision Equipmentreportable segment | segment assets | at 2024-03-31 | ¥4.1bn |
| Precision Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥831m |
| SP Divisionreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥33,000 |
| SP Divisionreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥735m |
| SP Divisionreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥735m |
| SP Divisionreportable segment | segment assets | at 2024-03-31 | ¥230m |
| SP Divisionreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥36m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥90m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥290m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥906m |
| Medical Equipmentreportable segment | employees | at 2025-03-31 | 86 pure |
| Precision Equipmentreportable segment | employees | at 2025-03-31 | 117 pure |
| SP Divisionreportable segment | employees | at 2025-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,640
| Item | Context | Value | Unit |
|---|---|---|---|
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000HatayamaMikioMember | Original text (Japanese)（注）３ | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000FukazawaTakahisaMember | Original text (Japanese)取締役（監査等委員） | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000FukazawaTakahisaMember | Original text (Japanese)深沢 岳久 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000FukazawaTakahisaMember | 1969-06-07 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E01109-000FukazawaTakahisaMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000FukazawaTakahisaMember | Original text (Japanese)（注）３ | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000ArisawaMasatoMember | Original text (Japanese)取締役（監査等委員） | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000ArisawaMasatoMember | Original text (Japanese)有沢 正人 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000ArisawaMasatoMember | 1960-07-27 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E01109-000ArisawaMasatoMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000ArisawaMasatoMember | Original text (Japanese)（注）３ | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000TanakaIzumiMember | Original text (Japanese)取締役（監査等委員） | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000TanakaIzumiMember | Original text (Japanese)田中 泉 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000TanakaIzumiMember | 1988-02-18 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E01109-000TanakaIzumiMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01109-000TanakaIzumiMember | Original text (Japanese)（注）３ | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | Original text (Japanese)持株会を通した購入による増加 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)㈱鳥羽洋行 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)㈱りそなホールディングス | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)㈱日伝 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)オカモト㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)大木ヘルスケアホールディングス㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)ウエルシアホールディングス㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)㈱マツキヨココカラ＆カンパニー | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)・医療機器事業において取引関係にあり、製品開発及び販売機会の増大を目的として保有しておりました。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)ＣＢグループマネジメント㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)有 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |